PADCEV (enfortumab vedotin-ejfv) can cause severe and fatal cutaneous adverse reactions including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which occurred predominantly ...
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University ...
Amram Kahn, MD, shares strategies for reconciling disparate clinical recommendations to optimize medication regimens for ...
With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...
Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...
Over the last decade, goal-directed management of osteoporosis has been developed as a concept. In 2024, a working group of ...
Expanding on IVBM insights, Robert Kratzke, MD, discusses biomarkers, NGS panels, and treatment options for early-stage NSCLC without actionable alterations.
If you have type 2 diabetes, your doctor may recommend Actos as a treatment for your condition. It’s a prescription drug used together with diet and exercise to help improve blood sugar levels in ...
Farxiga may cause some weight loss in people with type 2 diabetes. The amount and speed of weight loss from Farxiga vary for each person. Farxiga helps lower blood sugar by removing more sugar through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results